Boehringer Ingelheim GmbH and Sanofi SA have become the latest pharmaceutical companies to swap assets in a bid to strengthen their respective market positions in veterinary medicines and consumer healthcare products. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
